276 related articles for article (PubMed ID: 22441997)
21. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Perumpail RB; Wong RJ; Ahmed A; Harrison SA
Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
[TBL] [Abstract][Full Text] [Related]
22. Novel therapeutic targets for steatohepatitis.
Sanyal AJ
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S46-50. PubMed ID: 26160474
[TBL] [Abstract][Full Text] [Related]
23. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
Oh MK; Winn J; Poordad F
Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991
[TBL] [Abstract][Full Text] [Related]
24. [Is non alcoholic steatohepatitis (NASH) part of the metabolic syndrome?].
Fehér J; Németh E; Lengyel G
Orv Hetil; 2004 Jul; 145(29):1499-506. PubMed ID: 15453020
[TBL] [Abstract][Full Text] [Related]
25. An overview of nonalcoholic steatohepatitis: past, present and future directions.
Pascale A; Pais R; Ratziu V
J Gastrointestin Liver Dis; 2010 Dec; 19(4):415-23. PubMed ID: 21188334
[TBL] [Abstract][Full Text] [Related]
26. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.
Patton HM; Sirlin C; Behling C; Middleton M; Schwimmer JB; Lavine JE
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):413-27. PubMed ID: 17033514
[TBL] [Abstract][Full Text] [Related]
27. [Nonalcoholic fatty liver disease: 30 years research changed NASH].
Ratziu V; Poynard T
Gastroenterol Clin Biol; 2009; 33(8-9):850-8. PubMed ID: 19540686
[TBL] [Abstract][Full Text] [Related]
28. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic fatty liver disease.
Krawczyk M; Bonfrate L; Portincasa P
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):695-708. PubMed ID: 20955971
[TBL] [Abstract][Full Text] [Related]
30. [Metabolic syndrome and the liver (NAFLD/NASH)].
Hůlek P; Dresslerová I
Vnitr Lek; 2009; 55(7-8):646-9. PubMed ID: 19731869
[TBL] [Abstract][Full Text] [Related]
31. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
Balmer ML; Dufour JF
Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
[TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic steatohepatitis and the metabolic syndrome.
Neuschwander-Tetri BA
Am J Med Sci; 2005 Dec; 330(6):326-35. PubMed ID: 16355018
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
35. The diagnosis and treatment of non-alcoholic fatty liver disease.
Altinbas A; Sowa JP; Hasenberg T; Canbay A
Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK; Sanyal AJ
Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and diagnosis of NAFLD/NASH.
Hashimoto E; Taniai M; Tokushige K
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
[TBL] [Abstract][Full Text] [Related]
38. [Non-alcoholic steatohepatitis--a new epidemic].
Maier KP
Praxis (Bern 1994); 2007 Nov; 96(47):1857-60. PubMed ID: 18062158
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment.
Argyrou C; Moris D; Vernadakis S
J BUON; 2017; 22(1):6-20. PubMed ID: 28365930
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
